Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Leukemia, Myeloid, Acute 14Myelodysplastic Syndromes 7Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myelomonocytic, Chronic 2Triple Negative Breast Neoplasms 1Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Leukemia, Biphenotypic, Acute 1Hodgkin Disease 1GATA2 Deficiency 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Merkel Cell 1BRCA1 Mutation 1Anemia, Refractory, with Excess of Blasts 1Allogeneic Stem Cell Transplantation 1

Interventions

Carboplatin 71pembrolizumab 70Pemetrexed 62Cisplatin 46Nivolumab 28Paclitaxel 27durvalumab 26Specimen Handling 25osimertinib 23Docetaxel 23Magnetic Resonance Spectroscopy 21Gemcitabine 17Cetuximab 15130-nm albumin-bound paclitaxel 15atezolizumab 14amivantamab 14Radiotherapy 12Radiosurgery 12lazertinib 11Ipilimumab 9Bevacizumab 9cemiplimab 8Taxes 8Drug Therapy 8alectinib 7Ramucirumab 7Observation 7Radiation 6Leucovorin 5Immunoglobulin G 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × decitabine and cedazuridine drug combination × 30 days × Clear all
NCT02998567 2026-05-12

HyPeR

Royal Marsden NHS Foundation Trust

Phase 1 Active not recruiting
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡